Received Jun 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Pain following vaccination.; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a female patient who received Herpes zoster (Shingrix) solution for injection for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: Pain following vaccination.). The outcome of the pain was unknown. The reporter considered the pain to be unrelated to Shingrix. The company considered the pain to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 27-MAY-2026 The patient had all 3 vaccines.